The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation

“Triple-Punch” Strategy for Triple Negative Breast Cancer Therapy with Minimized Drug Dosage and Improved Antitumor Efficacy

(2015) Shishuai Su et al.   ACS Nano

New approaches for improving outcomes in breast cancer in Europe

(2015) Angelo Di Leo et al.   BREAST

Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2

(2015) Eric F. Zhu et al.   CANCER CELL

Contribution of the immune system to bystander and non-targeted effects of ionizing radiation

(2015) Franz Rödel et al.   CANCER LETTERS

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

(2015) Carsten Denkert et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiation therapy in the locoregional treatment of triple-negative breast cancer

(2015) Meena S Moran   LANCET ONCOLOGY

Management of locally advanced breast cancer—perspectives and future directions

(2015) Konstantinos Tryfonidis et al.   Nature Reviews Clinical Oncology

Current Clinical Trials Testing Combinations of Immunotherapy and Radiation

(2015) Marka Crittenden et al.   SEMINARS IN RADIATION ONCOLOGY

Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing

(2015) Sofia R. Gameiro et al.   Oncotarget

Influence of Lifestyle Factors on Breast Cancer Risk

(2014) Max Dieterich et al.   Breast Care

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

(2014) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy

(2014) Udo S Gaipl et al.   Immunotherapy

Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells

(2014) Lorenz Kulzer et al.   Journal of Immunotoxicology

How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?

(2014) W. F. Anderson et al.   JNCI-Journal of the National Cancer Institute

Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation

(2014) Roman Hennel et al.   Radiation Oncology

Immunological aspects of radiotherapy

(2014) Heike Scheithauer et al.   Radiation Oncology

Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines

(2014) Yvonne Rubner et al.   Radiation Oncology

Hypofractionation with simultaneous integrated boost for early breast cancer

(2014) Kathrin Dellas et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

(2013) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

(2013) Joanne S Haviland et al.   LANCET ONCOLOGY

DEGRO practical guidelines: radiotherapy of breast cancer I

(2013) F. Sedlmayer et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Breast Radiotherapy: Less is More?

(2012) C.E. Coles et al.   CLINICAL ONCOLOGY

Old and new facts about hyperthermia-induced modulations of the immune system

(2012) Benjamin Frey et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Simultaneous radiotherapy and superficial hyperthermia for high-risk breast carcinoma: A randomised comparison of treatment sequelae in heated versus non-heated sectors of the chest wall hyperthermia

(2012) Sumeeta Varma et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia

(2012) G. Bruggmoser et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Dying cell clearance and its impact on the outcome of tumor radiotherapy

(2012) Kirsten Lauber et al.   Frontiers in Oncology

The Challenge of Integrating Radiotherapy in the Multimodal Treatment of Breast Cancer

(2011) Rainer Souchon et al.   Breast Care

Electrochemotherapy of chest wall breast cancer recurrence

(2011) Gregor Sersa et al.   CANCER TREATMENT REVIEWS

Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells

(2011) R. Aguilera et al.   CLINICAL CANCER RESEARCH

5033 POSTER Re-irradiation Plus Hyperthermia for 415 Patients With Recurrent Breast Cancer in Previously Irradiated Area – the Amsterdam + Tilburg Experience

(2011) S. Oldenborq et al.   EUROPEAN JOURNAL OF CANCER

Hsp70, a messenger from hyperthermia for the immune system

(2011) Anna Jolesch et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Triple-Negative Breast Cancer: An Unmet Medical Need

(2011) C. A. Hudis et al.   ONCOLOGIST

Disrupted Lymph Node and Splenic Stroma in Mice with Induced Inflammatory Melanomas Is Associated with Impaired Recruitment of T and Dendritic Cells

(2011) Saïdi M. Soudja et al.   PLoS One

Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages

(2011) Petra Schildkopf et al.   RADIOTHERAPY AND ONCOLOGY

Biological Rationales and Clinical Applications of Temperature Controlled Hyperthermia - Implications for Multimodal Cancer Treatments

(2010) P. Schildkopf et al.   CURRENT MEDICINAL CHEMISTRY

DNA Repair Targeting and Radiotherapy: A Focus on the Therapeutic Ratio

(2010) John Thoms et al.   SEMINARS IN RADIATION ONCOLOGY

Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer

(2010) Stephan Ludwig Roth et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

(2009) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody

(2009) M. Z. Dewan et al.   CLINICAL CANCER RESEARCH